Our mission is to become the world’s leading supplier of naturally grown and processed, standardized medicinal-grade cannabis oil extracts and related products.
PharmaCielo Ltd. is a global company privately held and headquartered in Canada. PharmaCielo Colombia Holdings S.A.S., its wholly owned operating subsidiary, is headquartered in Rionegro, Colombia.
Canada was selected as the ideal country in which to headquarter our global parent based on its high standards of financial accountability and regulatory oversight. Additionally, Canada is lauded for its leadership in having established an innovative and highly regulated national medical cannabis industry.
Colombia was selected as our operational base due to its outstanding climatic and economic conditions, as well as its clear and legal framework for cannabis licensing, which together position the country to be the most cost-competitive and environmentally friendly nation on the planet for producing large volumes of all natural cannabis products.
We think that the combination of the two – Canada and Colombia – is a winning corporate structure for developing a sustainable international business with the ability to capture a significant share of the rapidly growing medical cannabis industry.
PharmaCielo employs a hybrid B2B and B2C sales and distribution model. However, with respect to B2C channel sales, PharmaCielo does not plan to market its products directly to end consumers, but rather through channel distributors.
In all B2C relationships, PharmaCielo intends to be either highly visible on product packaging as the headline brand, in the case of PharmaCieloTM branded products, or as PharmaCielo InsideTM in private label and other instances.
Our targeted B2B customers will primarily consist of finished goods manufacturers, research organizations and pharmaceutical companies.
Where We Are Now
On December 22nd, 2015, Colombian President Juan Manuel Santos signed regulatory Decree 2467 that codifies the path by which companies can apply for and obtain processing and extraction (oils and related products), cultivation and exportation licences for scientific and medical purposes.
Subsequently, on February 2, 2016, PharmaCielo became the first company to formally apply to the Colombian Ministry of Health and the National Drug Counsel (Consejo Nacional de Estupefacientes) for licensing consideration.
PharmaCielo was granted the country's first cannabis processing and extraction licence, on June 28, 2016. On October 23, 2017, PharmaCielo received the first Colombian licences for the cultivation of cannabis with unrestricted percentages of tetrahydrocannabinol (THC) and cannabidiol (CBD) alike. The Company intends to complete the requirements to become a licensed exporter as soon as possible.
PharmaCielo is now commencing cultivation and processing of large volumes of premium quality, all natural cannabis flower into highly standardized, medicinal-grade oil extracts and related products.
All aspects of our production model are designed to be flexible and easily scalable to meet global market demand. We will be able to consistently and cost effectively supply existing ready-for-import markets as well as rapidly increase export capacity as new medical cannabis markets open.